161 related articles for article (PubMed ID: 8827069)
21. Anaplasia and drug selection-independent overexpression of the multidrug resistance gene, MDR1, in Wilms' tumor.
Re GG; Willingham MC; el Bahtimi R; Brownlee NA; Hazen-Martin DJ; Garvin AJ
Mod Pathol; 1997 Feb; 10(2):129-36. PubMed ID: 9127318
[TBL] [Abstract][Full Text] [Related]
22. Focal versus diffuse anaplasia in Wilms tumor--new definitions with prognostic significance: a report from the National Wilms Tumor Study Group.
Faria P; Beckwith JB; Mishra K; Zuppan C; Weeks DA; Breslow N; Green DM
Am J Surg Pathol; 1996 Aug; 20(8):909-20. PubMed ID: 8712292
[TBL] [Abstract][Full Text] [Related]
23. Gene expression analysis of blastemal component reveals genes associated with relapse mechanism in Wilms tumour.
Maschietto M; Piccoli FS; Costa CM; Camargo LP; Neves JI; Grundy PE; Brentani H; Soares FA; Camargo Bd; Carraro DM
Eur J Cancer; 2011 Dec; 47(18):2715-22. PubMed ID: 21703850
[TBL] [Abstract][Full Text] [Related]
24. Quality assessment for Wilms' tumor: a report from the National Wilms' Tumor Study-5.
Ehrlich PF; Ritchey ML; Hamilton TE; Haase GM; Ou S; Breslow N; Grundy P; Green D; Norkool P; Becker J; Shamberger RC
J Pediatr Surg; 2005 Jan; 40(1):208-12; discussion 212-3. PubMed ID: 15868587
[TBL] [Abstract][Full Text] [Related]
25. [Wilms' tumor (nephroblastoma) of the adult].
Alvaro Naranjo T; Algarra García R; Carazo Tirao A; Cueva Ruiz C
Actas Urol Esp; 1992 May; 16(5):426-9. PubMed ID: 1324564
[TBL] [Abstract][Full Text] [Related]
26. Anaplastic nephrogenic rest.
Argani P; Collins MH
Am J Surg Pathol; 2006 Oct; 30(10):1339-41. PubMed ID: 17001170
[No Abstract] [Full Text] [Related]
27. The management of relapsed Wilms tumor.
Miser JS; Tournade MF
Hematol Oncol Clin North Am; 1995 Dec; 9(6):1287-302. PubMed ID: 8591966
[TBL] [Abstract][Full Text] [Related]
28. Number of mitotic figures in microscopic picture of nephroblastoma histologic types--estimation of the value of the oldest known prognostic factor.
Taran K; Kobos J; Sporny S
Pol J Pathol; 2008; 59(1):43-7. PubMed ID: 18655370
[TBL] [Abstract][Full Text] [Related]
29. Anaplastic Wilms' tumor: clinical and pathologic studies.
Bonadio JF; Storer B; Norkool P; Farewell VT; Beckwith JB; D'Angio GJ
J Clin Oncol; 1985 Apr; 3(4):513-20. PubMed ID: 2984344
[TBL] [Abstract][Full Text] [Related]
30. Defective chromosome segregation and telomere dysfunction in aggressive Wilms' tumors.
Stewénius Y; Jin Y; Øra I; de Kraker J; Bras J; Frigyesi A; Alumets J; Sandstedt B; Meeker AK; Gisselsson D
Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6593-602. PubMed ID: 18006759
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of nuclear unrest and p53 immunostaining in Wilms' tumor.
Salama A; Kamel A
J Egypt Natl Canc Inst; 2011 Mar; 23(1):31-9. PubMed ID: 22099934
[TBL] [Abstract][Full Text] [Related]
32. [Prognostic factors in Wilms' tumor].
Bezanilla JL; González Casaseca T
An Esp Pediatr; 1985 Aug; 23(2):125-9. PubMed ID: 2998250
[No Abstract] [Full Text] [Related]
33. [The assessment of nephroblastoma therapy results using the SIOP 92-01 protocol].
Madziara W; Bohosiewicz J
Wiad Lek; 1998; 51 Suppl 3():106-9. PubMed ID: 9814117
[TBL] [Abstract][Full Text] [Related]
34. Current management of Wilms' tumor in children.
Ko EY; Ritchey ML
J Pediatr Urol; 2009 Feb; 5(1):56-65. PubMed ID: 18845484
[TBL] [Abstract][Full Text] [Related]
35. [Nephroblastoma in children. Results of treatment (1989-1994)].
Sachivko NV; Drekov AG; Kochubinskiĭ VD; Sharak EV
Vopr Onkol; 1997; 43(4):422-5. PubMed ID: 9381695
[TBL] [Abstract][Full Text] [Related]
36. Immediate nephrectomy versus preoperative chemotherapy in the management of non-metastatic Wilms' tumour: results of a randomised trial (UKW3) by the UK Children's Cancer Study Group.
Mitchell C; Pritchard-Jones K; Shannon R; Hutton C; Stevens S; Machin D; Imeson J; Kelsey A; Vujanic GM; Gornall P; Walker J; Taylor R; Sartori P; Hale J; Levitt G; Messahel B; Middleton H; Grundy R; Pritchard J;
Eur J Cancer; 2006 Oct; 42(15):2554-62. PubMed ID: 16904312
[TBL] [Abstract][Full Text] [Related]
37. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
38. Adult Wilms' tumor: A monoinstitutional experience and a review of the literature.
Terenziani M; Spreafico F; Collini P; Piva L; Perotti D; Podda M; Gandola L; Massimino M; Cereda S; Cefalo G; Luksch R; Casanova M; Ferrari A; Polastri D; Valagussa P; Fossati-Bellani F
Cancer; 2004 Jul; 101(2):289-93. PubMed ID: 15241825
[TBL] [Abstract][Full Text] [Related]
39. Anaplastic Wilms' tumor. Initial diagnosis by fine needle aspiration.
Drut R; Pollono D
Acta Cytol; 1987; 31(6):774-6. PubMed ID: 2827412
[TBL] [Abstract][Full Text] [Related]
40. Analysis of Cox-2 expression in Wilms' tumor.
Giordano G; Campanini N; Donofrio V; Bertolini P; Falleti J; Grassani C; Pettinato G
Pathol Res Pract; 2008; 204(12):875-82. PubMed ID: 18752906
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
